Is Transpact Enter. overvalued or undervalued?
As of October 7, 2025, Transpact Enter. is considered very expensive and overvalued, with a PE ratio of 9.13, an EV to EBITDA ratio of 9.12, and a low ROE of 1.00%, despite a strong recent stock performance of 27.93% compared to the Sensex's 1.08%.
As of 7 October 2025, the valuation grade for Transpact Enter. has moved from risky to very expensive. This indicates a significant shift in perception regarding the company's valuation. Based on the analysis, Transpact Enter. is currently overvalued. The company's PE ratio stands at 9.13, while its EV to EBITDA ratio is also at 9.12, which is notably high compared to its peers. Furthermore, the ROE is only 1.00%, suggesting limited profitability relative to its equity.In comparison to its peers, Transpact Enter. shows stark contrasts; for instance, Poly Medicure has a PE ratio of 52.62, and Blue Jet Health stands at 32.53, both indicating much higher valuations based on earnings. The PEG ratio for Transpact Enter. is 0.00, which further emphasizes its lack of growth potential relative to its price. While the company's recent stock performance has outpaced the Sensex, with a 1-year return of 27.93% compared to the Sensex's 1.08%, this does not mitigate the concerns regarding its current overvaluation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
